Report Description
E-Clinical Trials Solutions/Suite/Technologies Market
Increasing adoption of new software solutions in clinical research It takes approximately 13 years and an overall investment of up to US$1.3 billion (~US$146 million per year) to bring a successful drug candidate to market; this includes initial drug screening, product synthesis, preclinical and clinical studies, as well as filing and regulatory approval. Therefore, researchers increasingly prefer innovative eClinical solutions that provide better clinical trial efficiency, improve site performance, and simplify research workload with better cost effectiveness than conventional methodologies. These software solutions allow pharmaceutical companies and independent researchers to compare the operational characteristics of software design options; model, predict and monitor clinical trial enrollment; and identify procedural bottlenecks associated with clinical trials. The procedural and operational advantages offered by eClinical solutions are resulting in significant growth in the adoption of these solutions among independent CRO researchers, as well as among pharmaceutical, medical device and biotechnology companies for their clinical research programs in order to organize, standardize and effectively manage clinical research. Data and metadata throughout the research lifecycle. Many integrated eClinical solutions provide clinical researchers with end-to-end solutions for all clinical trial processes. However, these software solutions are expensive and come with a steep price tag. Installation and maintenance of eClinical solutions cost approximately $2 million with additional technical support costs for cloud-based solutions. The high costs associated with eClinical's advanced software solutions are expected to limit their optimal adoption by small, price-sensitive users, including pharmaceutical companies, independent researchers, and CROs.E-Clinical Trials Solutions/Suite/Technologies Market Scope
CSP research recently published a report titled "(E-Clinical Trials Solutions/Suite/Technologies Market)" on the strength of the industry conjointly the} current and future trends that play a key role within the growth of the business. The report also highlights the drivers and barriers to growth. The report provides in-depth research and business growth insights. It examines necessary factors resembling value and offers future growth opportunities and forecasts supported their industry analysis. Throughout the study, researchers also study company profiles with details of the large players in the market today. The market segments are On the basis of Product (CDMS/EDC Solutions, CTMS Solutions, eCOA Solutions, RTMS Solutions, Safety Solutions, Analytics and Reporting Platforms, Integration Platforms, eTMF, Others), On the basis of components (Software, Hardware, Services), On the basis of Delivery Mode (Web-based (on-demand) Model, Licensed enterprise (on-premise) Model, Cloud-based (saas) Model), On the basis of Clinical trials Phase (Phase I, Phase II, Phase III, Phase IV), On the basis of End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutions)Competitive Landscape
Global E-Clinical Trials Solutions/Suite/Technologies Market report landscape includes company profiles with detailed data such as business overview, deals and specifications, key monetary metrics (total, gross and net), COVID19 impact analysis, SWOT analysis, market share, production and capacity (MW), key development activities, etc. for market makers are BioClinica, Inc, Signant Health, Datatrak International, Inc, ERT, eClinical Solutions, Inc, MaxisIT Inc, Bio-Optronics, Inc, Medidata Solutions, Inc, Parexel International Corporation, Merge Healthcare Incorporated, and OmniComm Systems, Inc.Regional Analysis
On the regional level presence, E-Clinical Trials Solutions/Suite/Technologies Market segmented into. North America, Europe, Latin America, Asia-Pacific including China and Middle East & Africa. This report is covered into geographically, with sales, revenue, market share and rate of growth E-Clinical Trials Solutions/Suite/Technologies Market in these regions. North America dominates the market and accounted for the largest revenue share. A growing target population, coupled with the increasing prevalence of lifestyle-related diseases such as diabetes and heart disease, is poised to drive the growth of the market. Additionally, new product launches by eClinical solution providers and increasing government subsidies are driving the market in the region. Furthermore, the presence of prominent players and the availability of sophisticated infrastructure are additional factors that are expected to accentuate the growth of the regional market. In Asia Pacific, the market for eClinical solutions is likely to grow. High unmet medical needs and increasing prevalence of targeted chronic diseases such as cancer, cardiovascular diseases and infectious diseases are fueling the demand for software solutions in the region. An increasing number of tests are outsourced to countries such as China, India, Korea and Japan. . Due to the large patient population and low cost. As an emerging economy, the market is largely driven by government funding related to research and drug discovery.E-Clinical Trials Solutions/Suite/Technologies Market Segments
On the basis of Product 1. CDMS/EDC Solutions 2. CTMS Solutions 3. eCOA Solutions 4. RTMS Solutions 5. Safety Solutions 6. Analytics and Reporting Platforms 7. Integration Platforms 8. eTMF 9. Others On the basis of Components 1. Software 2. Hardware 3. Services On the basis of Delivery Mode 1. Web-based (on-demand) Model 2. Licensed enterprise (on-premise) Model 3. Cloud-based (saas) Model On the basis of Clinical trials Phase 1. Phase I 2. Phase II 3. Phase III 4. Phase IV On the basis of End User 1. Pharmaceutical and Biopharmaceutical Companies 2. Contract Research Organizations 3. Consulting Service Companies 4. Medical Device Manufacturers 5. Hospitals 6. Academic Research Institutions Major Players covered in the Report 1. BioClinica Inc 2. Bio-Optronics Inc 3. Signant Health 4. Datatrak International Inc 5. ERT 6. eClinical Solutions Inc 7. MaxisIT Inc 8. Medidata Solutions Inc 9. Parexel International Corporation 10. Merge Healthcare Incorporated 11. OmniComm Systems Inc * Listed companies in this report may vary in the final report subject to Name Change / Merger etcGlobal E-Clinical Trials Solutions/Suite/Technologies Market: By Regional Analysis
1- North America A. U.S. B. Canada 2- Europe A. Germany B. U.K. C. France D. Italy E. Spain F. Rest of Europe 3- Asia Pacific A. China B. Japan C. India D. Rest of Asia Pacific 4- Latin America (LATAM) A. Brazil B. Mexico C. Rest of Latin America (LATAM) 5- Middle East & Africa (MEA) A. United Arab Emirates (UAE) B. Saudi Arabia C. Rest of Middle East & Africa (MEA) CSP Market Research analyst will gives you the thorough insightful information on E-Clinical Trials Solutions/Suite/Technologies Market Size, competitive landscape is delivered i.e. Revenue Share Analysis (MN USD) by top key Players, Revenue Market Share (%) by key Players and further a qualitative analysis is made headed for market cognizance rate, product differentiation, and new entrants are also considered in heat map concentration 1. Historical data- 2018 to 2019 2. The base year for estimation- 2020 3. Forecast period- 2021 to 2028Our Research Covers Competitors
1. Company Profile 2. Main Business Information 3. SWOT Analysis 4. Sales, Revenue, Price, and Gross Margin 5. Market ShareTarget Audience of the E-Clinical Trials Solutions/Suite/Technologies Market in this Study :
1. Key Consulting Companies & Advisors 2. Large, medium-sized, and small enterprises 3. Venture capitalists 4. Value-Added Resellers (VARs) 5. Third-party knowledge providers 6. Investment bankers 7. InvestorsKey Report Deliverables in the report E-Clinical Trials Solutions/Suite/Technologies Market
1- What is the market size and growth rate? 2- Inclusive details of factors that will challenge the growth of the market pre & post-COVID-19 with 4 types of market recovery scenarios including V shaped recovery, U shaped recovery, L shaped recovery, and W shaped recovery? 3- What are the factors anticipated to drive the global E-Clinical Trials Solutions/Suite/Technologies Market? 4- What are trends, restraints, and challenges in the global E-Clinical Trials Solutions/Suite/Technologies Market? 5- Segment-wise analysis of global E-Clinical Trials Solutions/Suite/Technologies Market? 6- Regional as well as country level analysis for E-Clinical Trials Solutions/Suite/Technologies Market? 7- Who are the potential customers of the global E-Clinical Trials Solutions/Suite/Technologies Market? 8- Analysis of major strategies by key market players? 9- How are collaborations evolving in the market? 10- How is the competitive environment? 11- Which region has attractive investment proposition? 12- Competitive Landscape with numerous analysis including revenue analysis, geographic presence analysis, competitive benchmarking, company evaluation matrix, competitive landscape, market positioning analysis, key strategies analysis, and others?Table of Content- Some Point Covered in the Report
Are you looking for a detailed TOC then speak with our analyst and fill the inquiry form. Chapter- 1. Research Framework keyword (Research Objective, Market Segmentation). Chapter- 2. Research Methodology- Qualitative Research, Primary & Secondary Sources, Quantitative Research, Primary & Secondary Sources, Market Size Estimation, Data Triangulation Chapter- 3. Executive Summary (Overview) Chapter- 4. Market Dynamics- Global Industry Outlook, Porter's Five Forces Model, COVID-19 Impact Assessment on Market, Major Strategies Adopted by Key Players, Market Positioning of Key Players Chapter- 5. Global keyword Analysis, by Market Segmentation- Key Insights, Market Size, and Forecast Chapter- 6. Global keyword Analysis, by Geography- Key Insights, Market Size, and Forecast (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). Chapter- 7. North America keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 8. Europe keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 9. Asia Pacific keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 10. Latin America keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 11. Middle East & Africa keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 12. Company Profiles- (Company, Company Basic Information, Manufacturing Base, Sales Area, Company Sales, and Net Income Highlights, Business Overview, Company News.Thanks for reading the article. We can also customize the report consistent with your requirements.
Geographical Analysis- Global Market Regional Analysis
What is the Report key Matric point?
|
Report Metric |
Details |
|
Market Study Available for Years |
2017–2030 Customize as per Requirement |
|
Base year Considered |
2020 Customize as per Requirement |
|
Historical Period |
2017- 2019 |
|
Forecast Period |
2021–2030 Customize as per Requirement |
|
Forecast Units |
Value (USD Million, Billion) As per Market |
|
Segments Covered |
Type, Application, and
Region- Customize as per Requirement |
|
Geographies Covered |
North America, Europe, Asia Pacific, Latin America, Middle East Africa and RoW- Customize as per Requirement |
Key Segments
E-Clinical Trials Solutions/Suite/Technologies Market Segments
On the basis of Product 1. CDMS/EDC Solutions 2. CTMS Solutions 3. eCOA Solutions 4. RTMS Solutions 5. Safety Solutions 6. Analytics and Reporting Platforms 7. Integration Platforms 8. eTMF 9. Others On the basis of Components 1. Software 2. Hardware 3. Services On the basis of Delivery Mode 1. Web-based (on-demand) Model 2. Licensed enterprise (on-premise) Model 3. Cloud-based (saas) Model On the basis of Clinical trials Phase 1. Phase I 2. Phase II 3. Phase III 4. Phase IV On the basis of End User 1. Pharmaceutical and Biopharmaceutical Companies 2. Contract Research Organizations 3. Consulting Service Companies 4. Medical Device Manufacturers 5. Hospitals 6. Academic Research InstitutionsMarket Segments Covered in the Report (Additional can be Customized)
Table of Content
Table of Content- E-Clinical Trials Solutions/Suite/Technologies Market
1. Introduction 1.1. Objective of the Study 1.2. Market Definition 1.3. Scope of the Study 1.3.1. Market Segmentation 1.3.1.1. E-Clinical Trials Solutions/Suite/Technologies Market, By Product 1.3.1.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Components 1.3.1.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode 1.3.1.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase 1.3.1.5. E-Clinical Trials Solutions/Suite/Technologies Market, By End User 1.3.1.6. E-Clinical Trials Solutions/Suite/Technologies Market, By Geography 1.4. Currency Used 1.5. Years Considered for the Study 1.5.1. Historical Years 1.5.2. Base Year 1.5.3. Forecast Years 1.6. Limitations 1.7. Stakeholders 2. Executive Summary 2.1. Market Snapshot: Global E-Clinical Trials Solutions/Suite/Technologies Market 2.1.1. Interconnectivity and Related Markets 2.2. Key Insights 2.3. DROC (Drivers, Restraints, Opportunities, and Challenges) Analysis 2.4. Demand Side Trends 2.5. Supply Side Trends 2.6. Strategic Overview for Global E-Clinical Trials Solutions/Suite/Technologies Market 2.7. Voice of Industry Experts/Key Opinion Leaders (KOLs) 2.8. Recommendations and Conclusions 3. Research Methodology 3.1. Research Data 3.2. Market Breakdown and Data Triangulation 3.2.1. Secondary Research 3.2.2. Primary Research 3.2.3. Internal Repository Knowledge 3.3. Market Sizing Approach 3.3.1. 3600 View 3.3.2. Bottom Up Approach 3.3.3. Top Down Approach 3.4. Data Sources 3.4.1. Secondary Sources 3.4.2. Primary Sources 3.5. Name of Sources and References 4. COVID-19 Impact 4.1. COVID-19 Prevalence Analysis* 4.2. COVID-19 Vaccine Analysis* 4.3. COVID-19 Impact on Global E-Clinical Trials Solutions/Suite/Technologies Market 4.4. Pre vs Post COVID Demand and Supply Analysis 4.5. COVID-19 Road to Recovery Analysis 4.5.1. Global E-Clinical Trials Solutions/Suite/Technologies Market V Shaped Recovery 4.5.2. Global E-Clinical Trials Solutions/Suite/Technologies Market U Shaped Recovery 4.5.3. Global E-Clinical Trials Solutions/Suite/Technologies Market L Shaped Recovery 4.5.4. Global E-Clinical Trials Solutions/Suite/Technologies Market W Shaped Recovery 4.6. COVID-19 impact on End-user Industry 4.7. COVID-19 Opportunity Analysis 5. Prominent Insights 5.1. Macro-Economic Factors 5.1.1. Regional GDP Outlook 5.1.2. Key Industry News 5.1.3. Global Market Trend 5.1.3.1. Positive Trends 5.1.3.2. Negative Trends 5.1.4. Mechanism Integration 5.2. Ecosystem Mapping and Opportunity Analysis 5.3. Developed Vs Developing Economies 5.4. Market Dynamics 5.4.1. Market Drivers 5.4.1.1. Driver 1 5.4.1.2. Driver 2 5.4.1.3. Driver 3 5.4.1.4. Global E-Clinical Trials Solutions/Suite/Technologies Market Drivers Impact Assessment in the short, medium, and long terms 5.4.1.5. Global E-Clinical Trials Solutions/Suite/Technologies Market Drivers Impact Assessment at Regional Level 5.4.2. Market Restraints 5.4.2.1. Restraint 1 5.4.2.2. Restraint 2 5.4.2.3. Restraint 3 5.4.2.4. Global E-Clinical Trials Solutions/Suite/Technologies Market Restraints Impact Assessment in the short, medium, and long terms 5.4.2.5. Global E-Clinical Trials Solutions/Suite/Technologies Market Restraints Impact Assessment at Regional Level 5.4.3. Market Opportunities 5.4.3.1. Opportunity 1 5.4.3.2. Opportunity 2 5.4.3.3. Opportunity 3 5.4.3.4. Global E-Clinical Trials Solutions/Suite/Technologies Market Opportunities Impact Assessment in the short, medium, and long terms 5.4.3.5. Global E-Clinical Trials Solutions/Suite/Technologies Market Opportunities Impact Assessment at Regional Level 5.4.4. Market Challenges 5.4.4.1. Challenge 1 5.4.4.2. Challenge 2 5.4.4.3. Challenge 3 5.4.4.4. Global E-Clinical Trials Solutions/Suite/Technologies Market Challenges Impact Assessment in the short, medium, and long terms 5.4.4.5. Global E-Clinical Trials Solutions/Suite/Technologies Market Challenges Impact Assessment at Regional Level 5.5. Porter?s Five Forces Analysis 5.5.1. Threat Of New Entrants 5.5.2. Threat Of Substitutes 5.5.3. Bargaining Power Of Suppliers 5.5.4. Bargaining Power Of Buyers 5.5.5. Rivalry Among Existing Competitors 5.6. Value Chain Analysis 5.7. Attractive Investment Proposition, By Geography 5.8. Investment Landscape 5.8.1. Market Major Mergers & Acquisitions 5.8.2. Market Fund Raise and Other Activities 6. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Product, 2017-2028 (US$ Mn) 6.1. Overview 6.1.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Product, Market Share Comparison 2020 vs 2028 (%) 6.2. CDMS/EDC Solutions 6.2.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By CDMS/EDC Solutions, Analysis and Forecast, 2017-2028 (US$ Mn) 6.2.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By CDMS/EDC Solutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.3. CTMS Solutions 6.3.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By CTMS Solutions, Analysis and Forecast, 2017-2028 (US$ Mn) 6.3.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By CTMS Solutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.4. eCOA Solutions 6.4.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By eCOA Solutions, Analysis and Forecast, 2017-2028 (US$ Mn) 6.4.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By eCOA Solutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.5. RTMS Solutions 6.5.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By RTMS Solutions, Analysis and Forecast, 2017-2028 (US$ Mn) 6.5.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By RTMS Solutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.6. Safety Solutions 6.6.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Safety Solutions, Analysis and Forecast, 2017-2028 (US$ Mn) 6.6.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Safety Solutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.7. Analytics and Reporting Platforms 6.7.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Analytics and Reporting Platforms, Analysis and Forecast, 2017-2028 (US$ Mn) 6.7.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Analytics and Reporting Platforms, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.8. Integration Platforms 6.8.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Integration Platforms, Analysis and Forecast, 2017-2028 (US$ Mn) 6.8.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Integration Platforms, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.9. eTMF 6.9.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By eTMF, Analysis and Forecast, 2017-2028 (US$ Mn) 6.9.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By eTMF, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.10. Others 6.10.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Others, Analysis and Forecast, 2017-2028 (US$ Mn) 6.10.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Others, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Components, 2017-2028 (US$ Mn) 7.1. Overview 7.1.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Components, Market Share Comparison 2020 vs 2028 (%) 7.2. Software 7.2.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Software, Analysis and Forecast, 2017-2028 (US$ Mn) 7.2.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Software, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7.3. Hardware 7.3.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Hardware, Analysis and Forecast, 2017-2028 (US$ Mn) 7.3.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Hardware, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7.4. Services 7.4.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Services, Analysis and Forecast, 2017-2028 (US$ Mn) 7.4.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Services, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Delivery Mode, 2017-2028 (US$ Mn) 8.1. Overview 8.1.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, Market Share Comparison 2020 vs 2028 (%) 8.2. Web-based (on-demand) Model 8.2.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Web-based (on-demand) Model, Analysis and Forecast, 2017-2028 (US$ Mn) 8.2.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Web-based (on-demand) Model, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8.3. Licensed enterprise (on-premise) Model 8.3.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Licensed enterprise (on-premise) Model, Analysis and Forecast, 2017-2028 (US$ Mn) 8.3.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Licensed enterprise (on-premise) Model, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8.4. Cloud-based (saas) Model 8.4.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Cloud-based (saas) Model, Analysis and Forecast, 2017-2028 (US$ Mn) 8.4.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Cloud-based (saas) Model, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Clinical trials Phase, 2017-2028 (US$ Mn) 9.1. Overview 9.1.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, Market Share Comparison 2020 vs 2028 (%) 9.2. Phase I 9.2.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase I, Analysis and Forecast, 2017-2028 (US$ Mn) 9.2.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase I, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.3. Phase II 9.3.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase II, Analysis and Forecast, 2017-2028 (US$ Mn) 9.3.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase II, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.4. Phase III 9.4.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase III, Analysis and Forecast, 2017-2028 (US$ Mn) 9.4.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase III, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.5. Phase IV 9.5.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase IV, Analysis and Forecast, 2017-2028 (US$ Mn) 9.5.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Phase IV, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By End User, 2017-2028 (US$ Mn) 10.1. Overview 10.1.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By End User, Market Share Comparison 2020 vs 2028 (%) 10.2. Pharmaceutical and Biopharmaceutical Companies 10.2.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Pharmaceutical and Biopharmaceutical Companies, Analysis and Forecast, 2017-2028 (US$ Mn) 10.2.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Pharmaceutical and Biopharmaceutical Companies, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10.3. Contract Research Organizations 10.3.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Contract Research Organizations, Analysis and Forecast, 2017-2028 (US$ Mn) 10.3.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Contract Research Organizations, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10.4. Consulting Service Companies 10.4.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Consulting Service Companies, Analysis and Forecast, 2017-2028 (US$ Mn) 10.4.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Consulting Service Companies, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10.5. Medical Device Manufacturers 10.5.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Medical Device Manufacturers, Analysis and Forecast, 2017-2028 (US$ Mn) 10.5.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Medical Device Manufacturers, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10.6. Hospitals 10.6.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Hospitals, Analysis and Forecast, 2017-2028 (US$ Mn) 10.6.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Hospitals, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10.7. Academic Research Institutions 10.7.1. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Academic Research Institutions, Analysis and Forecast, 2017-2028 (US$ Mn) 10.7.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Academic Research Institutions, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 11. Global E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 11.1. Overview 11.2. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Region, Market Share Comparison 2020 vs 2028 (%) 11.3. Global E-Clinical Trials Solutions/Suite/Technologies Market, By Region, Analysis and Forecast, 2017-2028 (US$ Mn) 11.4. Global E-Clinical Trials Solutions/Suite/Technologies Market, Regional Life Cycle Analysis 11.5. COVID-19 Impact on Global E-Clinical Trials Solutions/Suite/Technologies Market, By Region 12. North America E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 12.1. North America E-Clinical Trials Solutions/Suite/Technologies Market Overview 12.2. North America E-Clinical Trials Solutions/Suite/Technologies Market Summary 12.2.1. Dynamics 12.2.2. Impact Analysis 12.3. North America E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 12.4. North America E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 12.5. North America E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 12.6. North America E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 12.7. North America E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 12.8. North America E-Clinical Trials Solutions/Suite/Technologies Market, By Country, 2017-2028 (US$ Mn) 12.8.1. U.S. 12.8.1.1. Overview 12.8.1.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 12.8.1.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 12.8.1.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 12.8.1.5. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 12.8.1.6. E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 12.8.2. Canada 12.8.2.1. Overview 12.8.2.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 12.8.2.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 12.8.2.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 12.8.2.5. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 12.8.2.6. E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 13. Europe E-Clinical Trials Solutions/Suite/Technologies Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 13.1. Europe E-Clinical Trials Solutions/Suite/Technologies Market Overview 13.2. Europe E-Clinical Trials Solutions/Suite/Technologies Market Summary 13.2.1. Dynamics 13.2.2. Impact Analysis 13.3. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 13.4. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 13.5. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 13.6. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 13.7. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 13.8. Europe E-Clinical Trials Solutions/Suite/Technologies Market, By Country, 2017-2028 (US$ Mn) 13.8.1. Germany 13.8.1.1. Overview 13.8.1.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 13.8.1.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 13.8.1.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 13.8.1.5. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 13.8.1.6. E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 13.8.2. U.K. 13.8.2.1. Overview 13.8.2.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 13.8.2.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 13.8.2.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 13.8.2.5. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 13.8.2.6. E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 13.8.3. France 13.8.3.1. Overview 13.8.3.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 13.8.3.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 13.8.3.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2028 (US$ Mn) 13.8.3.5. E-Clinical Trials Solutions/Suite/Technologies Market, By Clinical trials Phase, 2017-2028 (US$ Mn) 13.8.3.6. E-Clinical Trials Solutions/Suite/Technologies Market, By End User, 2017-2028 (US$ Mn) 13.8.4. Italy 13.8.4.1. Overview 13.8.4.2. E-Clinical Trials Solutions/Suite/Technologies Market, By Product, 2017-2028 (US$ Mn) 13.8.4.3. E-Clinical Trials Solutions/Suite/Technologies Market, By Components, 2017-2028 (US$ Mn) 13.8.4.4. E-Clinical Trials Solutions/Suite/Technologies Market, By Delivery Mode, 2017-2
Key Players
Major Players covered in the Report 1. BioClinica Inc 2. Bio-Optronics Inc 3. Signant Health 4. Datatrak International Inc 5. ERT 6. eClinical Solutions Inc 7. MaxisIT Inc 8. Medidata Solutions Inc 9. Parexel International Corporation 10. Merge Healthcare Incorporated 11. OmniComm Systems Inc * Listed companies in this report may vary in the final report subject to Name Change / Merger etc
